OOIR: Observatory of International Research

Papers

(The H4-Index of Addiction is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta‐analyses (version 7)	189
Association of the COVID‐19 lockdown with smoking, drinking and attempts to quit in England: an analysis of 2019–20 data	170
Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis	118
Gateway or common liability? A systematic review and meta‐analysis of studies of adolescent e‐cigarette use and future smoking initiation	112
Expert appraisal of criteria for assessing gaming disorder: an international Delphi study	109
African Americans now outpace whites in opioid‐involved overdose deaths: a comparison of temporal trends from 1999 to 2018	99
Alcohol consumption during the COVID‐19 pandemic in Europe: a large‐scale cross‐sectional study in 21 countries	98
Shifts in alcohol consumption during the COVID‐19 pandemic: early indications from Australia	88
Drug checking services for people who use drugs: a systematic review	87
Heroin use cannot be measured adequately with a general population survey	72
A meta‐analysis of problem gambling risk factors in the general adult population	68
Treatment rates for alcohol use disorders: a systematic review and meta‐analysis	68
Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration	60
Causal mechanisms proposed for the alcohol harm paradox—a systematic review	55
Alcohol use in pregnancy and its impact on the mother and child	52
Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States	52
Global opioid agonist treatment: a review of clinical practices by country	52
Moderators of changes in smoking, drinking and quitting behaviour associated with the first COVID‐19 lockdown in England	52
Changes in alcohol consumption associated with social distancing and self‐isolation policies triggered by COVID‐19 in South Australia: a wastewater analysis study	50
The associations between prenatal cannabis use disorder and neonatal outcomes	48
COVID‐19, smoking, vaping and quitting: a representative population survey in England	48
Lessons from the public health responses to the US outbreak of vaping‐related lung injury	46
Electronic cigarettes, nicotine use trends and use initiation ages among US adolescents from 1999 to 2018	46
Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?	45
Similar countries, similar factors? Studying the decline of heavy episodic drinking in adolescents in Finland, Norway and Sweden	44

Text messaging interventions for reducing alcohol consumption among risky drinkers: systematic review and meta‐analysis	43
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA	41
Outcomes associated with the use of medications for opioid use disorder during pregnancy	40
Rapid growth in disposable e‐cigarette vaping among young adults in Great Britain from 2021 to 2022: a repeat cross‐sectional survey	40
Technology‐mediated just‐in‐time adaptive interventions (JITAIs) to reduce harmful substance use: a systematic review	40
Social norms as a predictor of smoking uptake among youth: a systematic review, meta‐analysis and meta‐regression of prospective cohort studies	39
Unknown population‐level harms of cannabis and tobacco co‐use: if you don't measure it, you can't manage it	39
Emotion regulation in substance use disorders: a systematic review and meta‐analysis	39
The science of recovery capital: where do we go from here?	39
Bidirectional effects between loneliness, smoking and alcohol use: evidence from a Mendelian randomization study	39
The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use	38
Controlled drinking—non‐abstinent versus abstinent treatment goals in alcohol use disorder: a systematic review, meta‐analysis and meta‐regression	38
Genetic liability for prescription opioid use and risk of cardiovascular diseases: a multivariable Mendelian randomization study	37
Alcohol control policy measures and all‐cause mortality in Lithuania: an interrupted time–series analysis	37